stars 1 stars 2 stars 3

Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.

Website http://www.replimune.com
Ticker REPL
Revenue $234.5 million
Funding $376 million
Employees 337 (320 on RocketReach)
Founded 2015
Address 500 Unicorn Park Dr Fl 3, Woburn, Massachusetts 01801, US
Phone +1 781-995-2443
Technologies
Industry Biotechnology Research, Pharmaceuticals, Health Care, Biotechnology, Healthcare, Medical, Therapeutics
Competitors Novartis, Merck & Co., Inc., Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Gilead Sciences +36 more (view full list)
SIC SIC Code 87 Companies, SIC Code 873 Companies
NAICS NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies

Replimune Questions

The Replimune annual revenue was $234.5 million in 2026.

Sushil Patel is the CEO of Replimune.

320 people are employed at Replimune.

Replimune is based in Woburn, Massachusetts.

The NAICS codes for Replimune are [5417, 54, 541714, 541, 54171].

The SIC codes for Replimune are [87, 873].

Top Replimune Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users